Form 4: Acadia Healthcare Director Ralph David Kelly Reports Acquisition of 2,414 Shares

Director Ralph David Kelly acquired 2,414 shares of Acadia Healthcare Company, Inc. on May 23, 2024, as reported in a Form 4 filing with the SEC.

Summary

• Ralph David Kelly, a director of Acadia Healthcare Company, Inc., filed a Form 4 with the SEC.
• The filing reports that Mr. Kelly acquired 2,414 shares of common stock on May 23, 2024, at a price of $0.0.
• These shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.
• Following the transaction, Mr. Kelly beneficially owns 8,072 shares of Acadia Healthcare Company, Inc.
• Mr. Kelly has also granted Brian Farley and Heather B. Dixon power of attorney to handle SEC filings on his behalf.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.

Positives

• A director increasing their stake in the company could be seen as a positive signal.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring transparency and compliance with SEC regulations.
• Similar filings are made by directors and officers of companies like Universal Health Services (UHS) and HCA Healthcare (HCA) when they engage in transactions involving their company's stock.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's confidence in the company.

Key Dates